: Data-Field 28000

Data-Field 28000

Description:	Antibody test result
Category:	Health outcomes ⏵ COVID-19 sub-studies ⏵ Coronavirus serology study waves 1-6 ⏵ Waves 1-6 sample processing

Participants

10,742

Categorical (single)

Both sexes

Nov 2022

59,890

Data

Defined (6)

Nov 2022

Complete

Primary

o1 s1

WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.

Data

59,890 items of data are available, covering 10,742 participants, encoded using Data-Coding 1854.
Defined-instances run from 0 to 5, labelled using Instancing 12.

Graph illustrating main data

6 Instances

Instance 0 : Wave 1 sample
10,742 participants, 10,742 items
Graph illustrating main data

Instance 1 : Wave 2 sample
10,411 participants, 10,411 items
Graph illustrating main data

Instance 2 : Wave 3 sample
10,218 participants, 10,218 items
Graph illustrating main data

Instance 3 : Wave 4 sample
10,028 participants, 10,028 items
Graph illustrating main data

Instance 4 : Wave 5 sample
9,736 participants, 9,736 items
Graph illustrating main data

Instance 5 : Wave 6 sample
8,755 participants, 8,755 items
Graph illustrating main data

Notes

Participants took a blood sample using a microsampling finger-prick device, and returned the sample to the UK Biobank laboratory, where they were processed to separate the blood components. The plasma was then shipped to an external laboratory where assays were conducted for IgG antibodies to the spike (S) protein.

0 Related Data-Fields

There are no related data-fields

4 Resources

Preview	Name	Res ID
	COVID-19 serology study waves 1-6 device specifications	4449
	COVID-19 serology study waves 1-6 instructional leaflet	4401
	COVID-19 serology study waves 1-6 test specifications	4448
	COVID-19 serology study waves 1-6 training video	4447

Enabling scientific discoveries that improve human health